What is Anal Cancer

TL;DR: Anal cancer is a malignancy that develops in the anal canal, the short tube at the end of the rectum through which stool leaves the body. While relatively rare compared to other gastrointestinal cancers, it is frequently associated with persistent human papillomavirus (HPV) infection, which triggers abnormal cell growth in the anal lining.

What exactly is anal cancer?

Anal cancer occurs when cells in the anal canal undergo genetic mutations, causing them to grow uncontrollably and form a tumor. Unlike colorectal cancer, which arises in the colon or rectum, anal cancer is distinct in its tissue origin and its strong link to viral factors. The disease primarily affects the squamous cells that line the anal canal, which is why the most common form is squamous cell carcinoma.

What are the primary subtypes and risk factors?

Understanding the classification of anal cancer helps guide treatment. The most common types include squamous cell carcinoma, adenocarcinoma, and basal cell carcinoma. Several factors increase the risk of developing the disease:

• HPV Infection: High-risk strains of HPV are detected in approximately 80-90% of all anal cancer cases.


• Immune Suppression: Individuals living with HIV or those who have received organ transplants are at a higher risk.


• Lifestyle Factors: Chronic inflammation and smoking are known contributors to the development of anal cancer.

How common is this condition?

Anal cancer is considered a rare disease in the general population, with an estimated annual incidence of approximately 1 to 2 cases per 100,000 people. While it can occur at any age, it is most frequently diagnosed in individuals between the ages of 50 and 60. Current data suggests a slightly higher prevalence in women, though this can vary based on regional HPV vaccination rates and screening practices.

How does it differ from other cancers?

It is vital to distinguish anal cancer from rectal cancer, as the treatment approaches differ significantly. While rectal cancer often requires surgical resection, anal cancer is uniquely sensitive to chemoradiotherapy, which is often the primary treatment to preserve anal function and avoid the need for a permanent colostomy.

Next steps

• Consult a gastroenterologist or colorectal surgeon if you notice symptoms like bleeding, pain, or a lump in the anal area.


• Join our community at DiseaseMaps.org to connect with 8 other members who have firsthand experience with anal cancer.


• Discuss HPV vaccination and screening options with your primary care provider to understand your individual risk profile.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center


• American Cancer Society: Anal Cancer Overview


• National Cancer Institute (NCI) - Anal Cancer Treatment (PDQ®)


• Orphanet: Rare Disease Database